Reimbursement: Up to £2,230 plus reasonable travel expenses

About This clinical research study

Eczema, also known as atopic dermatitis or atopic eczema, is one of the most common types of skin disease. Recurrent itching during an eczema flare-up is a common feature of this inflammatory skin condition. Currently there is no eczema cure, and many people struggle to identify how to treat eczema and how to stop eczema itching.

Many people living with eczema improve their condition, and relieve their symptoms using moisturising treatments, such as Aveeno™ eczema cream, medicines such as steroid creams, lifestyle changes and phototherapy (treatment with light).

At MAC Clinical Research we understand there is a need for patients to have the best eczema treatments available, including ointments, emollients and creams. We are currently conducting a clinical trial to test a new investigational topical ointment for the treatment of eczema.

The investigational medication, BEN2293, is being developed for the treatment of mild to moderate atopic dermatitis as an alternative to other creams and ointments currently available, such as hydrocortisone. The purpose of this trial is to see whether BEN2293 improves eczema in patients by breaking the itch scratch cycle, and to assess the effect of the ointment to the body.

Reimbursement: Up to £2,230 plus reasonable travel expenses


Greater Manchester, Lancashire, Merseyside, South Staffordshire, South Yorkshire, Teesside, & West Yorkshire

Therapy Area

Atopic Dermatitis

Gender and Age

Males and Females aged 18 - 65

A full description of the study will be given before you decide to take part, both over the phone and during an appointment at a MAC clinic. This will include you receiving the full patient information sheet and an opportunity to ask the study doctor any questions.

If you contact us, it does not mean you have to decide at that point whether to participate.
If you do decide to participate you are free to withdraw at any time.

The study will last between 8 weeks and 11 weeks and consist of 8 outpatient visits at either our Greater Manchester, Merseyside, South Staffordshire, Teesside, Lancashire, South Yorkshire, or West Yorkshire clinics.

Reimbursement: Up to £2,230 plus reasonable travel expenses

Key Inclusion Criteria

Key Exclusion Criteria

Other eligibility criteria will apply. Please contact MAC for more information.

If you are eligible you will receive a comprehensive health screen. Your GP will be fully informed of your participation and provided with any information relevant to your healthcare.


Clinical research studies are performed as a way of bringing about progress in medicine and research. Clinical research studies make it possible to scientifically assess the properties of a drug, to demonstrate the effectiveness and safety of a treatment or a medical device, or to learn more about a disease and methods to diagnose and monitor it.

If the study is successful, it may be an important step towards developing a promising new treatment.

MAC Clinical Research is conducting a trial to evaluate a potential new treatment for eczema.

If you would like more information, please fill in the form below and we will be in touch…

Alternatively, please call our recruitment team on freephone 0800 633 5507.

  • Hidden
  • Hidden
  • (You can enter any supporting information here)
  • Hidden
  • Hidden
  • Hidden
  • Hidden
  • Hidden
Data Privacy Statement

Know someone who may be interested in taking part? Share this page here: